Key result
Amplification of IL-2 mRNA from clinical biopsy specimens by polymerase chain reaction (PCR) provides a method to estimate cytokine protein levels.
This protocol provides a standardized PCR-based method for detecting cytokine mRNA expression in small clinical samples as an alternative to measuring protein levels.
Answers are grounded in this paper and cite their sources.
Supports PCR-based IL-2 mRNA detection in biopsies as protein surrogate; leaves open prospective validation before clinical adoption.
Assessment of cytokine expression during an immune response is a critical requirement for studies of basic immune mechanisms and the pathogenesis of disease. As an alternative to measuring cytokine protein levels, analysis of cytokine mRNA may be appropriate, because production of many cytokines is primarily transcriptionally regulated. Therefore, the level of cytokine mRNA present in a sample may serve as a good estimate of the level of cytokine protein present. This unit outlines the amplification of IL-2 mRNA from clinical biopsy specimens by the polymerase chain reaction (PCR), but the approach can be readily modified to study any cytokine RNA of interest in biopsies or small samples. In the Basic Protocol, cDNA is synthesized from the sample RNA by reverse transcriptase; to control for experimental variation in both the reverse transcription and PCR amplification steps, an internal control RNA is included in the reaction. Together, the reverse-transcribed cDNAs are amplified by PCR.
No takes yet. Share an insight, caveat, or question.
Stephen P. James (1994) studied this question. PCR amplification of cytokine mRNA was evaluated. Amplification of IL-2 mRNA from clinical biopsy specimens by polymerase chain reaction (PCR) provides a method to estimate cytokine protein levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: